This inventor holds 4 USPTO granted patents. Top assignees: Nisshin Flour Milling Co., Ltd., Fujisawa Pharmaceutical Company, Ltd.. Active years: 1984-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hachiohji, JP (1984)
- Hachioji, JP (1992)
- Tokyo, JP (1993)
Company Filing History:

Years Active: 1984-1993
Title: Innovations of Tatsuo Nagasaka
Introduction
Tatsuo Nagasaka is a notable inventor based in Hachioji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-platelet aggregating agents and nootropic agents. With a total of 4 patents to his name, Nagasaka's work has had a meaningful impact on medical science.
Latest Patents
Nagasaka's latest patents include an innovative anti-platelet aggregating agent that utilizes 1-phenoxycarbonyl-2-pyrrolidinone derivatives. These derivatives are characterized by the formula wherein R is a C1-C6 alkyl group, a C1-C6 alkoxy group, a nitro group, or a halogen atom, and n can be 0, 1, or 2. Additionally, he has developed 1-phenoxycarbonyl-2-pyrrolidinone derivatives that serve as nootropic agents, which are also defined by a specific formula. These compounds are particularly useful in enhancing cognitive functions.
Career Highlights
Throughout his career, Nagasaka has worked with prominent companies such as Nisshin Flour Milling Co., Ltd. and Fujisawa Pharmaceutical Company, Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.
Collaborations
Nagasaka has collaborated with notable colleagues, including Fumiko Hamaguchi and Einosuke Sakurai. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Tatsuo Nagasaka's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile